Johnson & Johnson (JNJ) Earnings Expected to Grow: Should You Buy?

Johnson & Johnson is expected to report Q3 2026 earnings of $2.90 per share (up 3.6% YoY) and revenues of $25.37 billion (up 5.8% YoY) on October 13. However, the company's Earnings ESP is -0.01% with a Zacks Rank #3, making it difficult to predict an earnings beat. While JNJ has beaten consensus estimates in all four of the last quarters, recent analyst revisions have turned slightly bearish, suggesting the stock may not be a compelling earnings-beat candidate.